Discover the dose reduction capabilities of Kinepict.

Home

Benefits

Substantial x-ray dose reduction

ICM dose reduction

Increased diagnostic insight

About Us

Team

Sites

Careers

Media & Publications

Peer-reviewed publications

Kinepict media

Newsroom

Footer Menu Center

Resources

Downloads

Funding

Contact

Log in

Privacy Policy

Footer Menu Right

Get in touch with us and let us show you how we can make X-ray angiography safer and more powerful with Kinepict.

By clicking &#8220;Request a demo&#8221; you accept our <a href="https://cms.kinepict.com/wp-content/uploads/2022/03/Privacy_policy.pdf">Privacy Policy</a>.

REQUEST a demo

kinepictlogo-1-2

KinepictLogo 1

illustration-2

Illustration (2)

illustration-1

Illustration (1)

Discover the dose reduction capabilities of Kinepict

illustration

Illustration

Learn more about the people behind Kinepict.

Discover the sites across Europe where Kinepict is used.

See our open positions and be part of our team!

Browse all peer reviewed publications examining the benefits of using Kinepict.

View our webinars, read our blog, listen to our podcast.

Discover how Kinepict appeared in the press.

Browse our useful resources to get the most out of Kinepict or download our medical certificates. 

Find answer to some of the most commonly asked questions about Kinepict.

LOG IN

Header

Accessibility statement
&nbsp;Introduction
Kinepict Health Ltd. is committed to providing a website that is accessible to the widest possible audience. Maintaining an accessible website is an ongoing process and we are continually working to provide the most inclusive experience we can. However, if you have any problems or feedback for us, please contact us at info@kinepict.com. This accessibility statement sets out how Kinepict Health Ltd. meets its obligations for user accessibility. This checklist confirms that Open Medical&rsquo;s website conforms with the Accessibility Requirements under the WCAG2.1 guidelines. We will update this statement as and when we make improvements.
Web Content Accessibility Guidelines (WCAG) explained
To make sure that our website and applications are accessible, we follow the World Wide Web Consortium&apos;s (W3C) Web Content Accessibility Guidelines (WCAG) version 2.1. WCAG is an accepted standard for measuring the accessibility of a website or app. It uses a scale A, AA and AAA to rate the accessibility of content. Kinepict Health Ltd., where possible, makes sure that its content meets at least AA compliance.
In order to meet WCAG standards
To make sure that our website is compliant with accessibility standards, our templates:
<ul>
 <li>use valid HTML and CSS</li>
 <li>are easy to navigate regardless of the input device or method</li>
 <li>have a logical content structure and a clear information hierarchy</li>
 <li>have layouts that adapt to different screen sizes without loss of functionality or usability</li>
 <li>provide sufficient color contrast between background and foreground items</li>
 <li>provide alternative text descriptions for non-text elements such as images</li>
 <li>We aim to use up-to-date modern web standards as a base for our website</li>
 <li>We avoid using technologies such as Flash which can restrict access for some users</li>
 <li>get from the start of the service to the end using just a keyboard</li>
 <li>listen to the service using a screen reader</li>
 <li>We&rsquo;ve also made the text in the service as simple as possible to understand</li>
</ul>
Accessibility of the Instructions for Use
The instructions for use of the Kinepict Medical Imaging Tool is available in PDF format under Resources / Downloads / User Manuals If you are a Kinepict Medical Imaging Tool user and would like to have a printed version of the document please contact us at <a href="mailto:info@kinepict.com">info@kinepict.com</a> or at +36-31-782-4019.
Direct link to the instructions for use: <a href="https://cms.kinepict.com/wp-content/uploads/2023/05/UM_V_6_0_final_compressed.pdf">LINK</a> The website and the link are available 24/7, 365 days a year.
The website
Kinepict Health Ltd&rsquo;s website (https://kinepict.com) contains public-facing information including details about our company, team, media content, solutions library and products library with case studies supporting our previous implementations. The site also includes information we are required to publish for legal, regulatory or statutory reasons. Our ongoing accessibility effort works towards conforming to the Web Content Accessibility Guidelines (WCAG) version 2.1, level AA criteria.
If you cannot access any information on our website and would like to request an alternative format, for example, an accessible PDF, large print document, easy read version, audio recording, please email us at info@kinepict.com or call us at +36-31-782-4019. We will try to provide you with an alternative version; however, there may be times when this is not possible. We aim to respond to requests within five working days, where possible. A few of the connecting links to other websites may not have the same behavior as the web pages hosted at <a href="https://kinepict.com/">https://kinepict.com</a>

Accessibility Statement

Digital Variance Angiography (DVA) is a proprietary innovative parametric imaging method that outperforms Digital Subtraction Angiography (DSA) in vascular imaging in the following three aspects: enhanced image quality, X-ray dose reduction, &nbsp;and contrast agent dose reduction. DVA technology is implemented in the CE-marked (Class IIa) and FDA-approved Kinepict Medical Imaging Tool, available for use in the operating room in Europe and the USA.
Cardiovascular disorders are the leading cause of death worldwide. Their diagnosis and treatment are key objectives of the global healthcare systems. Currently, Digital Subtraction Angiography (DSA) is the imaging method used for interventional radiology to visualize blood vessels in cardiovascular disorders &ndash; however, the image quality is not always appropriate (CO2 angiography) and the iodinated contrast media (ICM) and radiation applied during the procedure might cause complications for patients. A solution might be Digital Variance Angiography (DVA), a new image processing technology developed recently by Kinepict Health Ltd. The method is based on the principles of kinetic imaging [Szigeti et al., 2014], thereby it can obtain more information from medical examinations using penetrating radiation than the currently used image processing algorithms. In 2D X-ray angiography, the gold standard is DSA, which records a contrast-enhanced image series and subtracts one of these images (the mask) from the other frames. These subtracted images compose the DSA video and their appropriate integration yields the DSA image. In contrast, DVA uses all frames of an unsubtracted series and calculates the standard deviation of intensity for each pixel. This proprietary algorithm enhances the functional motion-related information (i.e. the flow of contrast agents) but suppresses the noise, therefore the contrast-to-noise ratio (CNR), and consequently the image quality is greatly improved compared to DSA, providing a quality reserve.
This quality reserve was verified in three recent clinical studies, where DVA provided higher CNR and better image quality than DSA in lower limb angiography using either iodinated contrast media [Gyano et al., 2019, Bastian et al., 2021] or carbon dioxide [Orias et al., 2019] as a contrast agent. The most important benefit of DVA is that the quality reserve can be used for dose management, i.e. for the reduction of radiation exposure or contrast media use. The dose management capabilities of DVA were investigated in two further clinical studies. The first study [Orias et al., 2020] investigated the possibility of contrast media reduction in X-ray carotid angiography. The authors applied two protocols; a normal one with 6 ml and a reduced one with 3 ml iodinated contrast media (ICM). According to the results, DVA provided better image quality than DSA in both protocols. While the reduction of ICM volume resulted in a very significant deterioration of DSA image quality, it had no effect on DVA image quality, indicating that the quality reserve of DVA allows a 50% ICM reduction without affecting the quality of angiograms.
The second study [Gyano et al., submitted] investigated the possibility of radiation exposure reduction in lower limb angiography. Again, a normal (1.2 &micro;Gy/frame) and a reduced (0.36 &micro;Gy/frame) protocol were used. The results show that DVA images obtained with the low dose protocol provide similar or even better image quality than DSA images with the normal dose, indicating that the quality reserve of DVA allows 70 % radiation dose reduction under these conditions.
The advantages of DVA are the most obvious in carbon dioxide angiography, where both he quality enhancement and dose management capabilities can be observed.
DVA technology is implemented in the Kinepict Medical Imaging Tool: X-Safe (Kinepict Health Ltd, Budapest). This is an angiography platform-independent software with a Class IIa CE mark and FDA approval. Integration of the Kinepict workstation into an angiography system provides a real-time operation during the intervention.
The KMIT workstation can be connected theoretically with any angiography system. So far more than several thousand patients were examined and 100,000 DVA images were generated in cooperation with Siemens, GE, and Philips suites in Hungary, Germany, and Austria. The software is clinically validated and used for daily routine work at 4 Hungarian cath labs. Since March 2021 we have accelerated our innovation process thanks to the EIC Accelerator Grant.

Digital Variance Angiography, a technological breakthrough in X-ray angiography

<a href="https://www.linkedin.com/pulse/experiences-fime-2022-from-viewpoint-hungarian-med-tech-l%25C3%25ADvia-bors">Read L&iacute;via&apos;s blog post on FIME Show</a> on LinkedIn (Florida International Medical Exhibition). On behalf of Kinepict Health Ltd. we are very proud of being a part of that this year!&nbsp;

Experiences on FIME 2022 from the viewpoint of a Hungarian med-tech company

<a href="https://www.linkedin.com/feed/update/urn:li:ugcPost:6972564170110062592?updateEntityUrn=urn%3Ali%3Afs_updateV2%3A%28urn%3Ali%3AugcPost%3A6972564170110062592%2CFEED_DETAIL%2CEMPTY%2CDEFAULT%2Cfalse%29">Read Buda's blog post </a>on LinkedIn about the annually held Beach Office and know more about our team building events.

Kinepict Beach Office

This year Kinepict has won the <a href="https://static.akcongress.com/downloads/irpa/irpa2022-programme-book.pdf">IRPA 2022 Startup Competition</a>.
IRPA 2022 Startup Competition 2022 is a regional European startup competition organized as a satellite event of the 6th European Congress on Radiation Protection (IRPA2022) that is dedicated to finding the most promising solutions and innovations in the radiation protection field.

Kinepict is the winner of the IRPA startup competition

Krisztián Szigeti has been chosen to be an Enterprise European Network Ambassador by <a href="https://www.linkedin.com/company/hepa-hungarian-export-promotion-agency/">HEPA Hungarian Export Promotion Agency </a>.

<img class="aligncenter wp-image-1733 size-full" src="https://cms.kinepict.com/wp-content/uploads/2022/12/1667549941564-1.jpeg" alt="" width="1115" height="750" />

Kinepict's CEO is the new Enterprise European Network Ambassador

This year our CEO and co-founder of Kinepict, Krisztián Szigeti has received the prestigious Dennis Gabor Award.

<img class="aligncenter wp-image-1763 size-large" src="https://cms.kinepict.com/wp-content/uploads/2022/12/GaborDenesDij-1024x683.jpeg" alt="" width="800" height="534" />

From the range of annual open nominations of professionals, the Foundation’s Board of Trustees identifies professionals who have actively contributed to the success of the economy through the introduction of their technical-intellectual creations, developmental results, establishing the infrastructural background of innovation, developing the creative thinking of the generations to come and conveying professional knowledge at a high level of quality.

The Foundation seeks to establish conditions worthy of the presentation of the awards.

Since 2005, the event has been hosted in the Hungarian Parliament Building.  The event in 2005 was attended by John Nicols, Ambassador of the United Kingdom of Great Britain and Northern Ireland, who also addressed those in attendance. During the last 15 years, the members of the Hungarian Government ordinarily participate in the celebration of laureated winners.

The awards are presented every year in December with the involvement of the Government of Hungary, in the presence of five hundred professional guests and the media.

Over the 30 years since the establishment of the award in 1989, Dennis Gábor awards have been presented to 239 (10 foreign) recipients, including international awards for six Hungarian, three American, one Austrian, one Russian and one Belgian national young researcher. A lifetime achievement award was presented to 1, “New generation” awards to 4 and “In memoriam Dennis Gábor” awards to 29 individuals.

Krisztián Szigeti has received the Dennis Gabor Award

One of our CEOs and co-founders; Krisztián Szigeti took part in the 3rd Digital Health Summit, as an invited speaker in the Health Startups Roundtable session together with Attila Máté (eHealth Software Solutions) and Gergely Szikszay-Molnár (Dermus).

Digital Health Summit is Hungary's first digital health conference for public and private health care, digital pharma, and manufacturers of digital medical products. The event was hosted at Corinthia Hotel, Budapest.

Thank you for this great opportunity!

<img class="wp-image-1725 size-full aligncenter" src="https://cms.kinepict.com/wp-content/uploads/2022/12/1669207141058.jpeg" alt="" width="800" height="533" />

Krisztián Szigeti took part in the 3rd Digital Health Summit, as an invited speaker

Our colleague, Dr. Peter Legeza has received the <a href="https://www.rsna.org/annual-meeting/awards-recognition/trainee-research-prize">Trainee Research Prize at RNSA 2022</a> with his work titled 'Digital Variance Angiography Significantly Reduces the Radiation Dose During Lower Extremity Diagnostic Angiographies Without Affecting the Image Quality'.

We are very proud and congratulate Dr. Legeza on his success. RSNA Daily Bulletin also published an interview about the topic. You can reach the article <a href="https://dailybulletin.rsna.org/db22/index.cfm?pg=22wed11">HERE.</a>

<img class="alignnone wp-image-1706 size-full" src="https://cms.kinepict.com/wp-content/uploads/2022/12/20221211_154219-1-scaled.jpg" alt="" width="1920" height="2560" />

&nbsp;

Peter Legeza received the Trainee Research Prize

<a href="https://www.linkedin.com/pulse/dear-pi-you-need-pm-now-zolt%25C3%25A1n-balogh-phd">Read Zolt&aacute;n&apos;s blog post</a> on LinkedIn about the role of project management in basic research.

Role of project management is research

Read, how Jules&apos; first ever USA trip transformed into a well-rounded, result-achieving, network-building, industry-stretching accomplishment on <a href="https://www.linkedin.com/pulse/tips-tricks-when-setting-foot-usa-market-julianna-dunavolgyi/">LinkedIn</a>.

Tips & Tricks For Medical Imaging Companies Looking to Enter The U.S. Market!

<a href="https://www.linkedin.com/pulse/welcome-my-world-hbba-event-london-julianna-dunavolgyi/">Read Julie's blog post</a> on LinkedIn about the Hungarian British Business Association's event in London.

Welcome to my world - HBBA event in London

<a href="https://www.linkedin.com/pulse/printfhello-world-olga-n%C3%A9meth/">Read Olga&apos;s blog note</a> on LinkedIn inspired by European Innovation Council and SMEs Executive Agency (EISMEA).

Women in the Profession

Collaborations & Reference Sites

Dr Viktor Orias's research founding on DVA

Dr. Balázs Nemes talks about the power of DVA technology when using CO2

Kinepict Knowledge Base Podcast - Advantages of DVA in transarterial chemoembolization of hepatocellular cancer

Kinepict Knowledge Base Podcast - Introduction

Kinepict Knowledge Base Podcast - Leadership Mini-Series

Kinepict Knowledge Base Podcast - Leadership Mini-Series II.

Kinepict Knowledge Base Podcast - Potential Benefits of DVA in Prostatic Artery Embolization

Kinepict Knowledge Base Podcast Leadership Mini Series #3

Learn more about Kinepict's DVA1 & DVA2 technology!

Radiation Reduction with Kinepict's DVA technology!

Dr. Harmat treated approximately 50 patients using Kinepict, and the results have been remarkable.

Testimonial: Dr. Zoltán Harmat

Greetings and introduction: Dr. Lorenzo Patrone, Dr. Balázs Nemes

Clinical evidence of Digital Variance Angiography

Better quality, fewer risks – how CO2 and X-Ray dose reduction can change your practice

Dr. Péter Sótonyi, Head of Department of the Vascular and Endovascular Surgery of Semmelweis University shares his experiences with Kinepict's technology

Testimonial: Dr. Péter Sótonyi

Dr. Balázs Nemes, Head of the Interventional Radiology Department of Semmelweis University shares his experiences with Kinepict's technology

Testimonial: Dr. Balázs Nemes

Case 1.: Common femoral artery balloon angioplasty

Case 2.: Femoro-popliteal multiplex balloon angioplasty

Kinepict Adacemy Live II. - Common femoral artery and femoro-popliteal multiplex angioplasty

A short and comprehensive explanation of the novel DVA technology compared the traditionally used DSA. Followed by the presentation of 2 cases where DVA-guided CO2 angiography was performed:

Case 1.: Cimino-Brescia fistula CO2 angiography and balloon angioplasty

Case 2.: CO2 angiography of the femoropopliteal region, balloon angioplasty, and self-deploying stent implantation